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Functional status of elderly adults 
before and after initiation of dialysis
Kurella Tamura et al., N Engl J Med 2009; 361: 1539–1547
Nephrologists have considerable and accurate statistics and metrics 
to share with patients regarding life expectancies when dialysis is 
initiated. However, we have not had the same vigorous information 
to share with patients with respect to the quality of their lives. In this 
study, Kurella Tamura et al. examine how elderly patients’ functional 
statuses, as the parameter of likely quality of life, change upon initia-
tion of dialysis, correlated with mortality. To identify nursing home 
residents starting dialysis, this study used US Renal Data System 
data linked with data from the Minimum Data Set. The Minimum 
Data Set contains functional status evaluations for eating, dressing, 
toileting, maintaining personal hygiene, walking, transferring from 
a chair to a standing position, and changing positions in bed. Each 
activity receives a score of 0 to 4 for total scores ranging from 0 
(independent) to 28 (severe functional impairment). For end-stage 
renal disease patients who would become nursing home residents, 
functional scores were similar throughout the year preceding the 
initiation of dialysis and worsened slightly during the last quarter 
before the initiation of dialysis. After initiation of dialysis, mortality 
rates (cumulative) were 24% at 3 months, 41% at 6 months, 51% at 
9 months, and 58% at 12 months. Patients surviving to a year expe-
rienced substantial worsening in functional status, with median 
functional status scores moving from 12 to 16. Combining the end 
points of death or decline in functional status, only 61% and 87% 
of nursing home residents receiving dialysis at 3 and 12 months, 
respectively, had died or had a decrease in functional status. Nurs-
ing home residents saw an annual change in function as an increase 
in scores of 2.2 points during the 12 months before the initiation of 
dialysis and 1.4 points for the 12 months after initiation; the decline 
was more pronounced among older or hospitalized residents.
We have minimal literature to help us inform patients as to what 
to expect when they begin dialysis. However, these data provide 
key information, allowing us to inform patients and their families 
of the potential loss of independence during or following the ini-
tiation of dialysis and to help them to manage their expectations. 
Additionally, we may begin to play a larger role in conversations 
regarding more substantive end-of-life issues. The ability and desire 
of patients and their families to be well-informed are integral to 
making joint decisions with their health-care providers, hopefully 
translating to improved quality-of-life outcomes over time.
Lynda Szczech
NADPH oxidase-4 mediates 
myofibroblast activation
Hecker et al., Nat Med 2009; 15: 1077–1081; doi:10.1038/nm.2005
Many renal diseases are characterized by marked fibrosis, a process 
in which generation of new epithelia is impaired and myofibroblasts 
are activated. Myofibroblasts can be activated by transforming 
growth factor-β1 (TGF-β1), matrix signaling, and biomechanical 
tension. It was previously reported that myofibroblast differentia-
tion by TGF-β1 was associated with activation of a flavoenzyme that 
generates extracellular hydrogen peroxide (H2O2) and that NOX-4, 
a member of the NADPH oxidase (NOX) family of enzymes, was 
involved in the differentiation of cardiac fibroblasts into myofibro-
blasts. The NOX enzymes catalyze the reduction of O2 to reactive 
oxygen species. Seven isoforms of the NOX family have been iden-
tified in mammals, but their specific roles are unclear. The best-
established physiological role of NOX enzymes is in host defense 
against pathogen invasion; NOX-2 is expressed in phagocytic cells 
and mediates microbicidal activities. Interestingly, recent work 
in kidney allografts suggests that NOX-2 may be involved in the 
pathogenesis of allograft fibrosis via epithelial-to-mesenchymal 
transition and myofibroblast activation. Recently, Hecker et al. 
identified NOX4 as one of the most highly induced genes in human 
fetal lung mesenchymal cells stimulated with TGF-β1. They also 
found that NOX-4-dependent generation of H2O2 was required 
for TGF-β1-induced myofibroblast differentiation and extracell-
ular matrix production. Further, NOX-4 was upregulated in lungs 
of mice subjected to noninfectious injury and in those of humans 
with idiopathic pulmonary fibrosis (Figure). Of great interest was 
the finding that genetic or pharmacologic targeting of NOX-4 
abrogated fibrogenesis in two models of lung injury. These studies 
support a function for NOX4 in tissue fibrogenesis and suggest that 
NOX-4 could be a therapeutic target in fibrotic diseases.
Juan Oliver
CD4+ T cells control the differentiation 
of Gr1+ monocytes into fibrocytes
Niedermeier et al., Proc Natl Acad Sci USA 2009; 106: 17892–17897; 
doi:10.1073/pnas.0906070106
The discussion about the origin of the myofibroblast-like cells 
responsible for the production of the matrix material constitut-
ing the fibrosis of the renal interstitium in progressive chronic 
renal failure has a long history. Proposals range from expansion 
and conversion of the normal interstitial cells, to epithelial– or 
endothelial–mesenchymal transformation with cell migration, 
to migration and expansion of vascular pericytes, to infiltration 
by bone marrow-derived monocytoid cells, including so-called 
Immunohistochemical staining showing expression of NOX-4 in 
myofibroblastic foci in lungs of a representative human subject with 
idiopathic pulmonary fibrosis.
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fibrocytes. With some experimental support for most of these pos-
sibilities, a mixture of all of these mechanisms seemed like a fair 
compromise. Now, Niedermeier et al. provide strong evidence that 
the infiltrating and matrix-producing cells in the renal intersti-
tium may be bone marrow-derived monocytes that, under CD4+ 
T cell influence, convert into fibrocytes, collagen type I-producing 
cells. The authors analyzed which leukocyte subsets are required 
for generation of fibrocytes in mice, showing that murine fibro-
cytes develop from the sub-population of CD11b+ CD115+ Gr1+ 
monocytes under the control of CD4+ T cells. In the absence of 
CD4+ T cells, differentiation of fibrocytes was markedly reduced 
in vitro and in vivo. In the presence of CD4+ T cells, the character-
istics of T-cell activation critically determined the development 
of fibrocytes. Polyclonal activation of CD4+ T cells induced the 
release of soluble factors that completely prevented the outgrowth 
of fibrocytes and could be identified as interleukin (IL)-2, tumor 
necrosis factor (TNF), interferon-γ, and IL-4. Application of IL-2 
and TNF significantly reduced the appearance of fibrocytes and 
the severity of fibrosis in the model of unilateral ureteral obstruc-
tion (UUO). In contrast, activation of CD4+ T cells in the pres-
ence of calcineurin inhibitors, but not mTOR inhibitors, markedly 
enhanced the outgrowth of fibrocytes and renal deposition of colla-
gen I. Taken together, these data show that differentiation of fibro-
cytes is critically dependent on CD4+ T cells. Most importantly, the 
context of T-cell activation determined whether the development 
of fibrocytes was supported or blocked.
These exciting data add to the recent support for T cells as 
being of great significance in the progression of renal diseases. 
Obviously, the identification of T cell-derived cytokines favoring 
or inhibiting fibrocyte generation may have major implications 
for therapeutic interventions designed to prevent the initiation 
and progression of fibrosis in native and transplanted kidneys, 
and potentially in fibrosing diseases of other organs.
Detlef Schlöndorff
Mechanism of BMP7-induced 
proliferation of nephron progenitors
Blank et al., Development 2009; 136: 3557–3566; doi:10.1242/dev.036335
Bone morphogenetic protein-7 (BMP7) has critical roles 
in embryonic and adult kidneys. It is a member of the BMP 
subfamily of proteins within the TGF-β superfamily. BMP7 
is heavily expressed in the adult kidney, particularly in podo-
cytes, distal tubules, and collecting ducts, and recent studies 
suggest that it is an integral part of the kidney’s reparative 
response to injury. BMP7 reverses epithelial-to-mesenchymal 
transition, and recombinant BMP7 has been shown to reduce 
renal fibrosis. The antifibrogenic activity of BMP7 results from 
inhibition of the nuclear translocation of TGF-β-activated 
SMAD3 by SMAD6 downstream of BMP7-activated SMAD5. 
During kidney development, generation of new nephrons 
occurs exclusively in the zone of the metanephric mesenchyme, 
which is adjacent to the tips of the branching ureteric bud. 
This region, known as the nephrogenic zone, is the niche for 
nephron progenitors, which must continually be replenished 
(that is, proliferate) while simultaneously differentiating to 
form new nephrons. Genetic deletion of SMAD7 in mice 
leads to severe impairment of kidney development, but in the 
Bmp7-null mouse, there is normal initiation of metanephric 
development and formation of a limited number of nephrons. 
However, nephron progenitors are prematurely depleted, and 
severe renal dysplasia results. Surprisingly, it was previously 
found that the nephrogenic zone is essentially unresponsive 
to SMAD-mediated transcriptional activation, leaving unex-
plained how BMP7 signals to maintain and replenish the 
population of nephron progenitors. In a recent publication, 
Blank et al. addressed this question. They found that cells iso-
lated from the nephrogenic zone were essentially refractory to 
SMAD-mediated transcriptional activation. However, in these 
cells BMP7 rapidly activated JNK signaling, resulting in phos-
phorylation of both Jun and ATF2 (Figure). They also found 
that BMP7 promoted proliferation of PAX2+ nephron progeni-
tor cells, and this effect involved TAK1-mediated JNK activa-
tion. Importantly, phosphorylation of both Jun and ATF2 in the 
mesenchyme next to the ureteric bud tips in Bmp7-null kidneys 
was significantly impaired compared with that in the wild type. 
Thus, BMP7 appears to promote maintenance and proliferation 
of nephron progenitors by directly activating the JNK–Jun–
ATF2 signaling axis in these cells. These findings provide an 
explanation for the deficiency of nephron progenitors during 
kidney development in Bmp7-null mice and open new avenues 
of inquiry concerning the actions of BMP7 in the kidney.
Juan Oliver
Unstimulated cells from the nephrogenic zone (i) and cells stimulated 
with 50 ng/ml BMP7 for 10 minutes (ii). Phosphorylated JNK (red), Six2 
(green), DAPI (blue). Arrows indicate SIX2+ cells, which robustly activate 
the JNK pathway upon BMP7 stimulation.
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Immunofluorescence of collagen I (Col I) (red) and quantification of the 
collagen I-positive area in sections of UUO kidneys of mice treated with 
IL-2 plus TNF or PBS (control). hpf, high-power field.
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